CTLT

Catalent

Halal Rating :
Uncomfortable
Last Price $63.49 Last updated:
Market Cap $11.03b
7D Change 0.66%
1 Year Change 44.61%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Pharmaceutical Preparations
Exchange NYSE
Next Earnings Date Nov. 11, 2024

Catalent Inc. is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies, and consumer health products. The company works with pharmaceutical, biotechnology, and consumer health companies to develop and deliver medicines, drugs, and consumer health products. Their core services include drug delivery technology development, drug substance development and manufacturing, drug product manufacturing, and clinical supply services.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $1.02b $1.15b - $60.0m 0.00% 5.22%
June 30, 2024 $1.3b $1.26b - $65.0m 0.00% 5.18%
March 31, 2024 $1.07b $1.16b - $65.0m 0.00% 5.62%

Company Impact

Help us evaluate Catalent's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates